LTR Pharma and EZZ Life Sciences have been promoted to a flagship global microcaps index, at the expense of Opthea.

The U.S. Food and Drug Administration is taking the first step to remove an ingredient in non-prescription cold medicines ...

ALK (ALKB:DC / OMX: ALK B) today announced that it has entered into a strategic license agreement with US-based ARS Pharmaceuticals, <a target= ...